Table 3.

Response to Treatment of the Patients With t(9; 11) and t(11q23)

Outcome3-150t(9; 11)t(11q23)3-151P
Treatment protocol (%) 
CALGB 8221, 8525 42 57 .58 
CALGB 8923 8 9 
CALGB 9022, 9222 50 35 
CR rate (%) 79 57 .13 
CR duration (median, mo) 10.7 8.9 .02 
EFS (median, mo) 6.2 2.2 .009 
Survival (median, mo) 13.2 7.7 .009 
Outcome3-150t(9; 11)t(11q23)3-151P
Treatment protocol (%) 
CALGB 8221, 8525 42 57 .58 
CALGB 8923 8 9 
CALGB 9022, 9222 50 35 
CR rate (%) 79 57 .13 
CR duration (median, mo) 10.7 8.9 .02 
EFS (median, mo) 6.2 2.2 .009 
Survival (median, mo) 13.2 7.7 .009 
F3-150

CR, complete remission; EFS, event-free survival.

F3-151

t(11q23), translocations involving band 11q23 other than t(9; 11).

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal